The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...

While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...

The FDA will select at most five companies that align with national priorities, including lower drug prices and increased ...

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...

The departure comes just days after the FDA's top vaccine official stepped down over disagreements with health secretary RFK Jr.'s over the safety of vaccinations.

The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...

New FDA Leadership Team: The FDA's top leadership has shifted under Commissioner Dr. Marty Makary, ... signals potential changes in FDA priorities and how the agency engages with biotech firms.

Industry leaders are lauding proposed changes to FDA’s food program outlined in a highly-anticipated external review by the Reagan-Udall Foundation published yesterday that includes calls for a ...

The leadership vacuum comes as Kennedy moves to fire 3,500 FDA staffers and pushes ahead with plans to scrutinize ultra-processed foods, childhood vaccines, antidepressants and other long ...